THE OBJECTIVE OF THIS CONTRACT IS TO GENERATE AN EFFECTIVE HIV VACCINE USING THE TARGETED AND CONTROLLED DELIVERY OF ANTIGENS TO ANTIGEN PRESENTING CELLS (APC). ENGINEERED NANOPARTICLES LOADED WITH MRNA CAPTURED BEHIND PH SENSITIVE POLYMER, TARGETED WITH MANNOSE WILL BE EMPLOYED TO INDUCE A HIV-SPECIFIC AND CELLULAR IMMUNE RESPONSE.

DEFINITIVE CONTRACT won by NANOCOMPOSIX, INC. · work in SAN DIEGO, CA
$600,000
RecipientNANOCOMPOSIX, INC. UEI EVQMBF7KC8P3
Award ID75N93019C00013
Award amount$600,000
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSCAN12
Set-asideSmall business
Start dateJun 17, 2019
End dateSep 16, 2022
Place of performanceSAN DIEGO, CA
Record updatedJan 27, 2023

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids